Cargando…

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway

BACKGROUND: LNK adaptor protein is a crucial regulator of normal hematopoiesis, which down-regulates activated tyrosine kinases at the cell surface resulting in an antitumor effect. To date, little studies have examined activities of LNK in solid tumors except ovarian cancer. METHODS: Clinical tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Jianxin, Yu, Wei, Zhang, Yanan, Cao, Xinhua, Han, Lifei, Hu, Haolin, Wang, Chenfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160949/ https://www.ncbi.nlm.nih.gov/pubmed/32322171 http://dx.doi.org/10.1186/s12935-020-01197-9

Ejemplares similares

The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
por: Morris, Rhiannon, et al.
Publicado: (2021)

Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding
por: Zhong, Zhao-Ming, et al.
Publicado: (2020)

Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer
por: López-Mejía, José A., et al.
Publicado: (2023)

YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells
por: Zhu, Xiaolong, et al.
Publicado: (2021)

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
por: Chang, Renxu, et al.
Publicado: (2018)

Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
por: Cheng, Jin-Zhang, et al.
Publicado: (2018)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple‐negative breast cancer by upregulating Ras/ERK and PI3K/Akt pathways
por: Zhu, Shan, et al.
Publicado: (2021)

C/EBPβ regulates the JAK/STAT signaling pathway in triple‐negative breast cancer
por: Wang, Shu, et al.
Publicado: (2021)

LNK suppresses interferon signaling in melanoma
por: Ding, Ling-Wen, et al.
Publicado: (2019)

BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway
por: Xu, Xiao-Feng, et al.
Publicado: (2019)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis
por: Wu, Liangcai, et al.
Publicado: (2020)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

COLD REGULATED GENE 27 and 28 antagonize the transcriptional activity of the RVE8/LNK1/LNK2 circadian complex
por: Sorkin, Maria L, et al.
Publicado: (2023)

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
por: Fang, Zhiqing, et al.
Publicado: (2013)

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
por: Song, Xiang, et al.
Publicado: (2020)

MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway
por: Jiang, Hongnan, et al.
Publicado: (2022)

LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway
por: Jia, Bo, et al.
Publicado: (2021)

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway
por: Yu, Chuigong, et al.
Publicado: (2022)

ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022)

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
por: Weihua, Zeng, et al.
Publicado: (2020)

CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
por: Zhang, Xiaowei, et al.
Publicado: (2018)

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
por: Du, Pengcheng, et al.
Publicado: (2019)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
por: Kang, Fu-biao, et al.
Publicado: (2015)

Merkel cell polyomavirus–negative Merkel cell carcinoma is associated with JAK‐STAT and MEK‐ERK pathway activation
por: Iwasaki, Takeshi, et al.
Publicado: (2021)

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
por: Gagliardi, Maria, et al.
Publicado: (2020)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways
por: Zhao, Jia, et al.
Publicado: (2021)

Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells
por: Gao, Jingchun, et al.
Publicado: (2013)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway
por: Li, Qianping, et al.
Publicado: (2019)

HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation
por: Wang, Tingting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ts3aknha5famhttkge9dthctj8